NASALCSF
DEAD

Serial Number

79395237

Owner

Noselab GmbH

Filing Date

Apr 9, 2024

Add to watchlist:

No watchlists yet
View on USPTO

NASALCSF Trademark

Serial Number: 79395237

NASALCSF is a trademark filed by Noselab GmbH on April 9, 2024. The trademark is classified under Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Noselab GmbH (8 trademarks)

Widenmayerstr. 27

Entity Type: 27

Trademark Details

Filing Date

April 9, 2024

Registration Date

Not Registered

Goods & Services

Medical testing services relating to the diagnosis and treatment of disease; medical analysis for the diagnosis and treatment of persons; medical services for the diagnosis of conditions of the human body; medical testing for diagnostic or treatment purposes; optical imaging for medical diagnostic use; regenerative medicine services; medical treatment services; medical information services provided via the internet; therapy services; performing diagnosis of diseases; medical examination; dietary and nutritional advice; dietetic advisory services; physiotherapy; nutrition consultancy; genetic counseling; medical consultations; physician services; therapeutic treatment of the body; medical counseling relating to stress; dna screening for medical purposes; mental health services; pharmaceutical services; medical services; medical services for the treatment of conditions of the human body; medical services relating to the removal, treatment and processing of human blood; medical services relating to the removal, treatment and processing of human cells; medical and health services relating to dna, genetics and genetic testing; consultancy and information services relating to medical products; psychological diagnosis services; medical analysis services for the diagnosis of cancer; medical analysis services for cancer diagnosis and prognosis; rna or dna analysis for cancer diagnosis and prognosis; medical services in the field of diabetes; health screening; advisory services relating to degenerative diseases; providing information via the internet in the field of diabetes; providing on-line information relating to the prevention of cardiovascular disease and strokes; advisory services relating to the treatment of degenerative diseases; preparation and dispensing of medications; providing information to patients in the field of administering medications.

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 12, 2026 FINT
FINAL DISPOSITION NOTICE SENT TO IB
Jan 30, 2026 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 30, 2026 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Oct 31, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 8, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Oct 8, 2025 OPNR
DEATH OF INTERNATIONAL REGISTRATION
Feb 8, 2025 DETH
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Jan 30, 2025 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jan 30, 2025 ABN2
REFUSAL PROCESSED BY IB
Jul 28, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 5, 2024 RFCS
REFUSAL PROCESSED BY MPU
Jul 5, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 15, 2024 RFCR
NON-FINAL ACTION WRITTEN
Jun 5, 2024 CNRT
ASSIGNED TO EXAMINER
Jun 4, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
May 15, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 15, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 9, 2024 REPR